Skip to main content
    P

    Pyxis Oncology Inc (PYXS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.41
    -0.17 (-10.76%)

    Market Cap: $188.98M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    52%(11/21)
    Avg Surprise
    -31.02%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.23
    Range-$0.30 - -$0.16
    11 analysts
    Revenue Consensus
    $19.83K
    RangeN/A
    11 analysts
    Reports May 12, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.21
    Range-$0.29 - -$0.16
    4 analysts
    EPS Revisions
    2
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.25+14.3%
    60d ago-$0.23+8.6%
    30d ago-$0.23+8.6%
    7d ago-$0.23+8.6%
    Current-$0.21
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-792.00%
    ROE-157.50%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio2.96xQuick Ratio2.96x
    Trading Statistics
    Beta1.41Avg Volume775.25K
    52-Week High$5.5552-Week Low$1.03

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 38.0% below its 50-day moving average, and the 50-day average is above the 200-day average. The 14-day RSI is 29.0, below 30, the oversold line.

    Moving Averages

    SMA 10$1.61
    SMA 20$1.70
    SMA 50$2.28
    SMA 200$2.16
    EMA 10$1.61
    EMA 20$1.73
    EMA 50$2.09
    EMA 200$2.29

    MACD

    Line: -0.18Signal: -0.20Hist: 0.01

    ADX

    ADX: 37.9+DI: 12.8-DI: 33.3

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$1.75

    Bollinger Bands

    Upper Band$1.95
    Lower Band$1.45
    %B Position2988%(Upper)
    Band Width-0.07

    RSI (14-Day)

    Oversold
    29.0

    Momentum Oscillators

    Stoch %K10.8
    Stoch %D18.3
    Williams %R-100.0
    ROC (10d)-16.6%
    Momentum-0.28
    CCI (20d)-177.5
    MFI (14d)21.6

    Volatility Measures

    ATR (14d)$0.15(10.6%)
    StdDev (20d)0.13
    Hist Vol75.7%(High)

    Volume Flow

    VWAP$1.46
    OBV-5.5M
    AD Line987.1K
    CMF (20d)-0.060

    Volume Metrics

    Avg Vol (20d)763.2K
    Vol Ratio1.1x
    VWMA (20d)$1.70

    Pivot Points

    R3$1.71
    R2$1.65
    R1$1.62
    Pivot Point$1.56
    S1$1.53
    S2$1.47
    S3$1.44

    Advanced Oscillators

    TSI-31.66
    Ultimate Osc38.1
    KST-234.33

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about PYXS

    News

    PYXS Valuation

    GNG's valuation label for PYXS is Overvalued.

    P/B
    2.8x
    All PYXS metrics

    PYXS Profitability: Margins, ROIC and FCF

    Pyxis Oncology (PYXS) has an operating margin of -792.0% and a net margin of 0.0%. It posts a -697.1% FCF margin.

    Operating margin
    -792.0%
    Net margin
    0.0%
    ROE
    -157.5%
    FCF margin
    -697.1%
    PYXS financial statements

    Pyxis Oncology Competitors

    The companies most similar to Pyxis Oncology (PYXS) include Compass Therapeutics, PolyPid and Innate Pharma.

    Sector: Healthcare

    Companies most similar to Pyxis Oncology

    PYXS Analyst Ratings

    Pyxis Oncology (PYXS) has a Buy consensus from 10 analysts: 9 Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    10
    Strong Buy
    1
    Buy
    8
    Hold
    1
    Sell
    0
    Strong Sell
    0
    PYXS stock forecast

    PYXS Bull Case vs Bear Case

    Bull case

    • 90.0% of PYXS's analyst ratings are Buy or Strong Buy.

    Bear case

    • PYXS beat EPS estimates in 37.5% of its last 8 reported quarters.

    PYXS Earnings: Beat Rate and Next Report

    Pyxis Oncology (PYXS) beat the EPS estimate in 3 of the last 8 quarters (37.5%). Its next report is expected on Mar 22, 2027.

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -40.3%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.23
    PYXS earnings history

    PYXS Earnings Date

    PYXS reports Mar 22, 2027. The date is estimated.

    PYXS ETF Holders

    GNG tracks 2 ETFs that hold PYXS. The largest weights:

    1. iShares Biotechnology ETF (IBB), 0.01% of the fund
    2. Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
    Open the ETF Stock Exposure tool for PYXS

    See insider activity

    Updated Nov 5, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About PYXS

    When does PYXS report earnings?

    Pyxis Oncology Inc (PYXS) is expected to report earnings on Mar 22, 2027.

    Does PYXS pay dividends?

    Pyxis Oncology Inc (PYXS) does not currently pay a regular dividend.

    What is PYXS's market cap?

    Pyxis Oncology Inc (PYXS) has a market capitalization of $188.98M with a current stock price of $1.41.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.